Clinical Trial Update: N-acetylcysteine for Tobacco Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial investigating N-acetylcysteine for tobacco use disorder has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Smoking

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Nicotine Dependence, Smoking | Phase 2 | Status: COMPLETED | Results posted: 2020-08-17